Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01949376 · ClinicalTrials.gov registry record
Mild Cognitive Impairment in Breast Cancer Patients
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 84
- Enrollment target
NCT01949376: Completed study, sponsored by Northwestern University.
NCT01949376 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01949376 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to improve our understanding of potential changes in size, shape and activity in some brain areas that can occur in women receiving different types of Breast Cancer therapy, and how these changes are related to the development of mild cognitive impairment as the result of these treatments.
Primary Outcome
Measured using a neuropsychological test battery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2013-06 |
| Est. Completion | 2019-12-31 |
What the finished NCT01949376 record still lists
NCT01949376 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01949376 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01949376 about?
NCT01949376 is a clinical study titled "Mild Cognitive Impairment in Breast Cancer Patients". The purpose of this study is to improve our understanding of potential changes in size, shape and activity in some brain areas that can occur in women receiving different types of Breast Cancer therapy, and how these changes are related to the development of mild cognitive impairment as the result o...
What is the current status of trial NCT01949376?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2013-06. Estimated completion is 2019-12-31.
Who is sponsoring clinical trial NCT01949376?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia